Anti-Inflammatory Action of Sitagliptin and Linagliptin in Doxorubicin Nephropathy

<b><i>Background/Aims:</i></b> Dipeptidyl peptidase-4 (DPP4) inhibitors are known to have a protective effect on diabetic kidney disease, possibly via reduction of oxidative stress and inflammation in the kidney. However, whether these potential mechanisms play a role in non-diabetic proteinuric kidney diseases is not clear. <b><i>Methods:</i></b> Two different animal experiments were carried out...